Elsevier

Ophthalmology

Volume 119, Issue 12, December 2012, Pages 2563-2571
Ophthalmology

Original article
Determinants of Retinal Venular Diameter: The Beaver Dam Eye Study

https://doi.org/10.1016/j.ophtha.2012.06.038Get rights and content

Objective

To describe how retinal venular diameter changes over time for an individual and to examine differences in these changes among people with different risk profiles.

Design

Population-based cohort study.

Participants

A total of 4600 persons aged 43 to 86 years from the Beaver Dam Eye Study (BDES) who participated in at least 1 examination and had venular diameter measured in the right eye.

Methods

Data from 4 examinations during a 15-year period were analyzed. Retinal venular diameter was measured from photographs at each examination by computer-assisted methods and summarized as the central retinal venular equivalent (CRVE). Associations of risk factors with concurrent CRVE measurements and changes in CRVE over time were determined using multivariate analyses.

Main Outcome Measures

Central retinal venular equivalent.

Results

The CRVE tended to narrow with age. Mean CRVE was approximately 5 μm smaller (225 vs. 230 μm) for the average 70-year-old compared with the average 50-year-old, and was approximately 13 μm smaller (217 vs. 230 μm) for the average 85-year-old compared with the average 50-year-old. Male sex (beta estimate [β] = 5.24; 95% confidence interval [CI], 3.58–6.90), history of current cigarette smoking (β = 9.38; 95% CI, 8.26–10.49), and higher white blood cell (WBC) count (per 1000/μL: β = 0.95; 95% CI, 0.74–1.16) were independently associated with larger concurrent CRVE, whereas higher mean arterial blood pressure (per 5 mmHg: β = −0.36; 95% CI, −0.50 to −0.23) and higher serum high-density lipoprotein (HDL) cholesterol (per 10 mg/dl: β = 0.89; 95% CI, −1.15 to −0.63) were independently associated with smaller concurrent CRVE. History of cardiovascular disease (CVD) (β = −0.16; 95% CI, −0.26 to −0.06) and presence of chronic kidney disease (CKD) (β = −0.20; 95% CI, −0.34 to −0.05) were associated with a greater decrease in CRVE over time.

Conclusions

These data show that retinal venular diameter tends to narrow with age; concurrent venular diameter is independently associated with sex, blood pressure, serum HDL cholesterol, WBC count, and history of current cigarette smoking; and change in CRVE is independently associated with a history of CVD and presence of CKD. The different independent effects of these interrelated factors on CRVE highlight the complex relationship between CRVE and systemic diseases and conditions and the difficulty in determining specific causes of change in CRVE over time.

Financial Disclosure(s)

The author(s) have no proprietary or commercial interest in any materials discussed in this article.

Section snippets

Population

A private census of Beaver Dam, Wisconsin, was performed in 1987 and 1988 to identify all residents aged 43 to 84 years.19 A total of 4986 of 5924 persons identified participated in the baseline examination (examination 1) from 1988 to 1990. Ninety-nine percent of the population were white, and 56% were female. The cohort was reexamined at 5- (n = 3722), 10- (n = 2962), and 15-year (n = 2375) follow-up examinations (examinations 2, 3, and 4, respectively). There was >80% participation among

Results

Of the 4926 individuals who participated in the BDES examination 1, 4739 had gradable CRVE in the right eye. Of these, 12 individuals were excluded because their photographs were taken using a non-Zeiss camera, 63 individuals were excluded because late AMD or treatment for AMD was present, 18 individuals were excluded because retinal vessel occlusion was present, 81 individuals were excluded because moderate to severe nonproliferative or proliferative retinopathy (Early Treatment Diabetic

Discussion

The BDES offered an opportunity to examine the associations of various factors (e.g., smoking status, serum total and HDL cholesterol, glycosylated hemoglobin level, and inflammatory markers) previously shown to be associated with CRVE and with changes in CRVE over time. Our study shows that CRVE tended to decrease with age, and many factors were related to concurrent CRVE and change in CRVE. However, in multivariate analysis, few of these relationships persisted, especially relationships with

References (56)

  • C. Sabanayagam et al.

    Bidirectional association of retinal vessel diameters and estimated GFR decline: the Beaver Dam CKD Study

    Am J Kidney Dis

    (2011)
  • T.Y. Wong et al.

    Estrogen replacement therapy and retinal vascular caliber

    Ophthalmology

    (2005)
  • M.K. Ikram et al.

    Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders?The Rotterdam Study

    Invest Ophthalmol Vis Sci

    (2004)
  • T.Y. Wong et al.

    Retinal vascular caliber, cardiovascular risk factors, and inflammation: the Multi-Ethnic Study of Atherosclerosis (MESA)

    Invest Ophthalmol Vis Sci

    (2006)
  • R. Klein et al.

    Are inflammatory factors related to retinal vessel caliber?The Beaver Dam Eye Study

    Arch Ophthalmol

    (2006)
  • T.Y. Wong et al.

    Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study

    Invest Ophthalmol Vis Sci

    (2004)
  • M.K. Ikram et al.

    Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study

    Diabetes

    (2006)
  • B.E. Klein et al.

    Complete blood cell count and retinal vessel diameters

    Arch Ophthalmol

    (2011)
  • G. Liew et al.

    Relative importance of systemic determinants of retinal arteriolar and venular caliber: the Atherosclerosis Risk in Communities study

    Arch Ophthalmol

    (2008)
  • C.Y. Cheung et al.

    C-reactive protein and retinal microvascular caliber in a multiethnic Asian population

    Am J Epidemiol

    (2010)
  • V.S. Jeganathan et al.

    Retinal vascular caliber and diabetes in a multiethnic Asian population

    Microcirculation

    (2009)
  • F.M. Islam et al.

    Quantitative retinal vascular calibre changes in diabetes and retinopathy: the Singapore Malay Eye Study

    Eye (Lond)

    (2009)
  • T.T. Nguyen et al.

    Relationship of retinal vascular caliber with diabetes and retinopathy: the Multi-Ethnic Study of Atherosclerosis (MESA)

    Diabetes Care

    (2008)
  • G. Tikellis et al.

    The relationship of retinal vascular calibre to diabetes and retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study

    Diabetologia

    (2007)
  • K. McGeechan et al.

    Meta-analysis: retinal vessel caliber and risk for coronary heart disease

    Ann Intern Med

    (2009)
  • M.K. Ikram et al.

    Retinal vessel diameters and risk of stroke: the Rotterdam Study

    Neurology

    (2006)
  • K. McGeechan et al.

    Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis

    Am J Epidemiol

    (2009)
  • T.Y. Wong et al.

    Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the Cardiovascular Health Study

    Arch Intern Med

    (2006)
  • Cited by (45)

    • Retinal vessel diameters and function in cardiovascular risk and disease

      2022, Progress in Retinal and Eye Research
      Citation Excerpt :

      However, retinal FID as a direct marker of endothelial function was unaffected by the surgical intervention. Dyslipidemia, another frequent co-morbidity of obesity, has also been shown to be related to alterations of the retinal microvascular phenotype (Ikram et al., 2004; Liew et al., 2008a; Myers et al., 2012; Wong et al., 2006a). In these studies, higher LDL cholesterol (Ikram et al., 2004; Liew et al., 2008a; Myers et al., 2012; Wong et al., 2006a), higher triglycerides (Wong et al., 2006a) and lower HDL cholesterol (Ikram et al., 2004; Wong et al., 2006a) were associated with wider CRVE.

    View all citing articles on Scopus

    Manuscript no. 2012-377.

    Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

    Supported by National Institutes of Health Grant EY-06594 (B.E.K.K. and R.K.) and by Research to Prevent Blindness (B.E.K.K. and R.K., Senior Scientific Investigator Awards), New York, New York. The National Eye Institute provided funding for the entire study, including data collection and analysis; R.P.B. provided additional support for data analysis. Neither funding organization had a role in the design or conduct of this research. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Eye Institute or the National Institutes of Health.

    View full text